// App-Quantinova.ai

: Genomic validation of three-tiered sub-classification of high-risk prostate cancer.

Researchers

Presenter

  • Vinayak Muralidhar

Principal Investigators

  • Jingbin Zhang

  • Daniel Eidelberg Spratt

  • Felix Y Feng

  • Elai Davicioni

  • Kasra Yousefi

  • Natalie Wang

  • Voleak Choeurng

  • Paul L. Nguyen

Medical Centers

  • Dana-Farber Cancer Institute, Boston, MA

  • GenomeDx Biosciences Inc., Vancouver, BC, Canada

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

  • Dana-Farber-Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA

Locations

  • United States

  • Canada

Companies

  • GenomeDx Biosciences

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • Prostate specific antigen

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved